Medical News

RSS

On quality of care, U.S. is not always best

The Washington Post interviewed Sen. Kent Conrad, D-N.D., about other developed nations' health care systems: "We won't adopt the German system or French system or anything of the like. But I think we can get clues on the fundamental differences of various systems," he said. Conrad added that the system that has "largely been adopted in France, Germany, Japan, Belgium and Switzerland, is not government-run.

25 Sep 2009

CBO scores on health bills raise questions

Various news outlets are examining the Congressional Budget Office's analysis of the cost of health bills.

25 Sep 2009

Finance committee agonizes over Medicare cuts

Politico reports: "The top Senate Republican says Democratic cuts to Medicare will cost them in the 2010 elections, warning that the hundreds of billions in reductions to the senior citizen health program is 'Orwellian.' Sen. Mitch McConnell (R-Ky.), the Senate minority leader, criticized Democrats for insisting that a half-trillion dollars in cuts to Medicare as part of the health care overhaul, well, aren't exactly cuts to Medicare.

25 Sep 2009

Affymax may sell up to.$60 million of its registered common stock to Azimuth Opportunity

Affymax, Inc. (Nasdaq:AFFY) today announced that it has obtained an issuer managed equity facility under which it may sell up to $60 million of its registered common stock to Azimuth Opportunity, Ltd. Affymax is not obligated to utilize any of the facility, which has a term of 24 months.

25 Sep 2009

Poll: More approve of Obama's handling of health care, but many still confused

The latest CBS News/New York Times poll finds that Americans are still confused and anxious about a health care overhaul.

25 Sep 2009

House passes bill to stop some Medicare premium increases

The House voted overwhelmingly to stop premium increases in Medicare Part B— which covers doctor visits — from taking effect next year.

25 Sep 2009

Labor chief asks for probe into health insurance lobbying

The Wall Street Journal/Dow Jones reports: "AFL-CIO President Richard Trumka on Thursday urged some state insurance commissioners to investigate how the costs of insurers' lobbying to defeat health-insurance reform are affecting premiums."

25 Sep 2009

Covidien declares 12.5% increase in quarterly dividend

Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a 12.5% increase in the quarterly dividend rate, from $0.16 per ordinary share to $0.18 per ordinary share.

25 Sep 2009

Joseph Gunnar retained as Medical Connections' exclusive investment banker

Medical Connections Holdings, Inc., one of the nation’s fastest growing healthcare staffing companies specializing in allied health, nurse and physician staffing and recruiting services, is pleased to announce it has retained New York City-based broker dealer Joseph Gunnar & Co as its exclusive investment banker.

25 Sep 2009

RXi Pharmaceuticals acquires self-delivering rxRNA technology platform from Advirna

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that it has recently acquired direct ownership of technology for which it had previously exercised its option to exclusively license from Advirna LLC.

25 Sep 2009

Jazz Semiconductor offers its Reliability Modeling Tool for high reliability applications in medical markets

Jazz Semiconductor, Inc., a Tower Group Company, today announced its pioneering Reliability Modeling Tool (RMT), offered free to its customers through its eBizz Web portal. The tool is critical for high reliability applications in aerospace, defense, automotive and medical markets.

25 Sep 2009

DOR Biopharma to raise $3.85 million from institutional investors

DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biotechnology company, announced today that it has entered into common stock purchase agreements with institutional investors totaling approximately $3.85 million. DOR's North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., participated in this financing.

25 Sep 2009

Hamilton Health Sciences contravening the collective agreement: Registered nurses of ONA

Thirty-seven registered nurses, members of the Ontario Nurses' Association (ONA) will attend an arbitration hearing in Hamilton tomorrow that will decide whether Hamilton Health Sciences will be allowed to continue to arbitrarily reassign nurses to other vacant positions within the hospital.

25 Sep 2009

Fourth-quarter and fiscal year end 2009 results announced by Noveko International

Noveko International Inc. ("the Company") today announces the financial results for its fourth quarter and fiscal year ended June 30, 2009.

25 Sep 2009

Levin Group to develop a practice integration program for BIOLASE dental lasers

BIOLASE Technology, Inc. today announced that it has engaged Baltimore-based Levin Group, Inc., a leading international dental practice consulting firm, to develop a practice management system for the successful integration and implementation of BIOLASE dental lasers into everyday dental offices.

25 Sep 2009

Growing public support for the use of ignition interlocks on the cars of drunk drivers: IIHS study

While a study released last week by the Insurance Institute for Highway Safety (IIHS) indicates growing public support for the use of ignition interlocks on the cars of drunk drivers, a growing body of justice officials and policymakers say the trend is actually dealing with the people--not just the cars--when it comes to mitigating the social and financial costs of the DUI epidemic.

25 Sep 2009

Dyax to present an update of its clinical development programs

Dyax Corp., a developer of novel biotherapeutics for unmet medical needs, announced today that Gustav A. Christensen, President and Chief Executive Officer of Dyax, will present at the Fourth Annual JMP Securities Healthcare Focus Conference, being held October 5-6th at The New York Palace Hotel in New York City, NY.

25 Sep 2009

NCI awards Altor Bioscience a $3 MM grant to develop its targeted cancer therapeutic ALT-801

Altor BioScience Corporation announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase II Bridge Grant by the National Cancer Institute (NCI). The award of $3 MM over three years will help Altor further its clinical development of ALT-801, a novel tumor-targeted immunotherapeutic designed to improve the efficacy and safety of the FDA-approved anticancer cytokine, interleukin-2 (IL-2).

25 Sep 2009

Investigational New Drug application for Uricase-PEG 20 approved

EnzymeRx, LLC, a clinical-stage biotechnology company, announced that its Investigational New Drug (IND) application for Uricase-PEG 20, filed with the U.S. Food and Drug Administration (FDA) last month, has become effective.

25 Sep 2009

AABM Team wins two medals in a national contest

The Aquatic Animal Bio-Medicine R&D Team (AABM Team) of National Cheng Kung University (NCKU) in Taiwan, led by Distinguished Prof. Huey-Lang Yang from Institute of Biotechnology, won two medals out of more than 100 teams in the national contest, “2009 Crazy Idea – King of Practical Applications on Creative Researches and Development of Biotechnology,” organized by the Industrial Development Bureau of the Ministry of Economic Affairs, Taiwan.

25 Sep 2009